The results also showed that patients with high PAQR3 expression in BRCA, KIRC, KIRP, and LIHC tumors had worse OS, indicating that PAQR3 was a risk factor affecting prognosis in these tumor types. The gene discussed is PAQR3; the disease is neoplasm.